en

Peer review 2011

  1. Arn KD, Dazzi H, Went P, Goede JS, Stüssi G. 2011. Erythroleukaemia at second glance. Eur J Haematol 86, no. 4 (Apr): 358-359.
     
  2. Balestra B, Gandolfi A, Giannini O, Selmoni G. 2011. Progetto Domino: introdurre la cultura del miglioramento organizzativo in un reparto di medicina interna. Quaderni di management, no. 52 (Aug): 73-80.
     
  3. Barreca A, Lasorsa E, Riera L, Machiorlatti R, Piva R, Ponzoni M, Kwee I, Bertoni F, Piccaluga PP, Pileri SA, Inghirami G, European T-Cell Lymphoma Study Group. 2011. Anaplastic lymphoma kinase in human cancer. J Mol Endocrinol 47, no. 1 (Jul): R11-23.
     
  4. Bassetti CL, Agazzi P, Bornatico-Valsangiacomo F, Carota A, Calabrese P, Cereda CW, Caporale CM, Galati S, Gobbi C, Manconi M, Möller JC, Pedrazzi PL, Raimondi M, Staedler C, Uncini A, Zecca C. 2011. Neurologie: Jahresrückblick 2010. Teil 1 Swiss Medical Forum 11, no. 19: 329-331.
     
  5. Bassetti CL, Agazzi P, Bornatico-Valsangiacomo F, Carota A, Calabrese P, Cereda CW, Caporale CM, Galati S, Gobbi C, Manconi M, Möller JC, Pedrazzi PL, Raimondi M, Staedler C, Uncini A, Zecca C. 2011. Neurologie: Jahresrückblick 2010. Teil 2 Swiss Medical Forum 1 (20): 350-353.
     
  6. Bassetti CL, Bornatico F, Fuhr P, Schwander J, Kallweit U, Mathis J, Swiss RLS study group. 2011. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial. Swiss Med Wkly, 141: w13274 (1-7). 
     
  7. Bassetti CL, Hermann DM. 2011. Sleep and stroke. Handb Clin Neurol 99: 1051-1072.
     
  8. Bassetti CL. 2011. Nonmotor disturbances in Parkinson's disease. Neurodegener Dis 8 (3): 95-108.
     
  9. Belcastro V, Pierguidi L, Tambasco N, Sironi L, Sacco L, Corso A, Taborelli A, Arnaboldi M. 2011. Decreased contralateral putamen [I]FP-CIT SPECT uptake in hyperglycemic hemichorea-hemiballismus. Eur Neurol 65 (5): 307-308.
     
  10. Bencini GM, Pozzan L, Bertella L, Mori I, Pignatti R, Ceriani F, Semenza C. 2011. When two and too don't go together: a selective phonological deficit sparing number words. Cortex 47, no. 9 (Oct): 1052-1062.
     
  11. Bertoni F, Coiffier B, Salles G, Stathis A, Traverse-Glehen A, Thieblemont C, Zucca E. 2011. MALT lymphomas: pathogenesis can drive treatment. Oncology (Williston Park) 25, no. 12 (Nov): 1134-1142, 1147.
     
  12. Bettinelli A, Aliprandi S, Bianchetti MG. 2011. Conditions underlying significant community-acquired hyponatremia in childhood. Acta Paediatr 100, no. 10 (Oct): e145-e146.
     
  13. Bianda N, Di Valentino M, Périat D, Segatto JM, Oberson M, Moccetti M, Sudano I, Santini P, Limoni C, Froio A, Stuber M, Corti R, Gallino A, Wyttenbach R. 2011. Progression of human carotid and femoral atherosclerosis: a prospective follow-up study by magnetic resonance vessel wall imaging. European Heart Journal 33, no. 2 (Jan): 230-237.
     
  14. Bignardi M, Navarria P, Mancosu P, Cozzi L, Fogliata A, Tozzi A, Castiglioni S, Carnaghi C, Tronconi MC, Santoro A, Scorsetti M. 2011. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Int J Radiat Oncol Biol Phys 81, no. 3 (Nov): 831-838.
     
  15. Boillat Blanco N, Probst A, Da Costa VW, Giulieri S, Bernasconi E, Calmy A, Elzi L, Rauch A, Weber R, Bertisch B, Cavassini M, Bochud PY. 2011. Impact of a nurse vaccination program on hepatitis B immunity in a Swiss HIV clinic. J Acquir Immune Defic Syndr 58, no. 5 (Dec): 472-474. 
     
  16. Bulian P, Tarnani M, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, Deaglio S, D'Arena G, Efremov D, Marasca R, Lauria F, Gattei V, Gaidano G, Laurenti L. 2011. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. Hematol Oncol 29, no. 2 (Jun): 91-99.
     
  17. Calderone R, Nimako K, Leary A, Popat S, O'Brien ME. 2011. Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease--a short communication. Eur J Cancer 47, no. 11 (Jul): 1603-1605.
     
  18. Capello D, Gloghini A, Martini M, Spina M, Tirelli U, Bertoni F, Rinaldi A, Morra E, Rambaldi A, Sinigaglia F, Larocca LM, Carbone A. 2011. Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas. Br J Haematol 152, no. 6 (Mar): 777-780.
     
  19. Caporale CM, Notturno F, Pace M, Aureli A, Di Tommaso V, De Luca G, Farina D, Giovannini A, Uncini A. 2011. CD1A and CD1E gene polymorphisms are associated with susceptibility to multiple sclerosis. Int J Immunopathol Pharmacol 24, no. 1 (Jan-Mar): 175-183.
     
  20. Caporale CM, Staedler C, Gobbi C, Bassetti CL, Uncini A. 2011. Chronic inflammatory lumbosacral polyradiculopathy: a regional variant of CIDP. Muscle Nerve 44, no. 5 (Nov): 833-837.
     
  21. Caracciolo A, Bettinelli A, Bonato C, Isimbaldi C, Tagliabue A, Longoni L, Bianchetti MG. 2011. Antimicrobial resistance among Escherichia coli that cause childhood community-acquired urinary tract infections in Northern Italy. Ital J Pediatr 37: 3.
     
  22. Carota A, Cereda C, Calabrese P, Rocchi S, Bassetti CL. 2011. Recovery from Nondominant Thalamopolar Artery Stroke. Eur Neurol 65 (2): 68-69.
     
  23. Cassano M, Dellavalle A, Tedesco FS, Quattrocelli M, Crippa S, Ronzoni F, Salvadè A, Berardi E, Torrente Y, Cossu G, Sampaolesi M. 2011. Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo. Development 138, no. 20 (Oct): 4523-4533.
     
  24. Cefali P, Rosso R, Van den Berg JC. 2011. Training of vascular surgeons by interventional radiologists. J Cardiovasc Surg (Torino) 52, no. 1 (Feb): 57-62.
     
  25. Cereda C, Staedler C, Moschovitis G, Caronni F, Bassetti CL, Azzola A. 2011. 'Bubbles in the brain': systemic air embolism syndrome from an atrial-oesophageal fistula. Emerg Med J 28, no. 5 (May): 455.
     
  26. Ceriani L, Suriano S, Ruberto T, Giovanella L. 2011. Could different hydration protocols affect the quality of 18F-FDG PET/CT images? J Nucl Med Technol 39, no.2 (Jun): 77-82.
     
  27. Cevoli S, Pizza F, Grimaldi D, Nicodemo M, Favoni V, Pierangeli G, Valko PO, Baumann CR, Montagna P, Bassetti CL, Cortelli P. 2011. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. Cephalalgia 31, no. 8 (Jun): 973-976.
     
  28. Chigrinova E, Mian M, Scandurra M, Greiner TC, Chan WC, Vose JM, Inghirami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJ, Franceschetti S, Gaidano G, Tucci A, Facchetti F, Lazure T, Lambotte O, Montes-Moreno S, Piris MA, Nomdedeu JF, Uccella S, Rancoita PM, Kwee I, Zucca E, Bertoni F. 2011. Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome. Hematol Oncol 29, no. 1 (Mar): 38-41.
     
  29. Chigrinova E, Mian M, Shen Y, Greiner TC, Chan WC, Vose JM, Inghirami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJ, Franceschetti S, Gaidano G, Tucci A, Facchetti F, Lazure T, Lambotte O, Montes-Moreno S, Piris MA, Zucca E, Kwee I, Bertoni F. 2011. Integrated profiling of diffuse large B-cell lymphoma with 7q gain. Br J Haematol 153, no. 4 (May): 499-503.
     
  30. Cianfoni A, Boulter DJ, Rumbold Z, Zapton T, Bonaldi G. 2011. Guidelines to Imaging Landmarks for Interventional Spine Procedures: Fluoroscopy and CT Anatomy. Neurographics - American Society of Neuroradiology (Special AJNR Supplements Celebrate 50 Years) 1, no. 1 (Jun): 39-48.
     
  31. Clivio A, Nicolini G, Vanetti E, Fogliata A, Cozzi L. 2011. Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities. Radiat Oncol 6: 129.
     
  32. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C, ESMO Guidelines Working Group. 2011. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22, no. 6 Suppl (Sep): vi35-vi39.
     
  33. Cortés B, Marazza G, Naldi L, Combescure C, Borradori L; Autoimmune Bullous Disease Swiss Study Group. 2011. Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol 165, no. 2 (Aug): 368-374.
     
  34. Dal Bo M, Rossi FM, Rossi D, Deambrogi C, Bertoni F, Del Giudice I, Palumbo G, Nanni M, Rinaldi A, Kwee I, Tissino E, Corradini G, Gozzetti A, Cencini E, Ladetto M, Coletta AM, Luciano F, Bulian P, Pozzato G, Laurenti L, Forconi F, Di Raimondo F, Marasca R, Del Poeta G, Gaidano G, Foà R, Guarini A, Gattei V. 2011. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. Genes Chromosomes Cancer 50, no. 8 (Aug): 633-643.
     
  35. Dal-Bo M, Del Giudice I, Bomben R, Capello D, Bertoni F, Forconi F, Laurenti L, Rossi D, Zucchetto A, Pozzato G, Marasca R, Efremov DG, Guarini A, Del Poeta G, Foà R, Gaidano G, Gattei V. 2011. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage. Br J Haematol 153, no. 1 (Apr):  3-14.
     
  36. Deabate L, Garavaglia G, Lucchina S, Fusetti C. 2011. Fracture of the radial sesamoid bone of the thumb: an unusual fracture. Chin J Traumatol 14, no. 5 (Oct): 309-311.
     
  37. Di Iulio J, Ciuffi A, Fitzmaurice K, Kelleher D, Rotger M, Fellay J, Martinez R, Pulit S, Furrer H, Günthard HF, Battegay M, Bernasconi E, Schmid P, Hirschel B, Barnes E, Klenerman P, Telenti A, Rauch A, Swiss HIV Cohort Study. 2011. Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology 53, no. 5 (May): 1446-1454.
     
  38. Di Valentino M, Gallino A, Klimusina J, Demertzis S, Menafoglio A. 2011. Typical signs of secundum atrial septal defect in a young man. Cardiovasc. Med. (CH) 14 (3): 98-100.
     
  39. Di Valentino M, Menafoglio A, Wyttenbach R, Gallino A. 2011. An Unusual Case of Recurrent Syncope. JACC 58, no. 16 (Oct): 1728.
     
  40. Dreyling M, Ghielmini M, Marcus R, Salles G, Vitolo U, ESMO Guidelines Working Group. 2011. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22, Suppl 6 (Sep): vi59-63.
     
  41. El Amari EB, Combescure C, Yerly S, Calmy A, Kaiser L, Hasse B, Furrer H, Cavassini M, Vernazza P, Hirsch H, Bernasconi E, Hirschel B, Swiss HIV Cohort Study. 2011.Clinical relevance of cytomegalovirus viraemia. HIV Med 12, no. 7 (Aug): 394-402.
     
  42. Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, Hirschel B, Hoffmann M, Bernasconi E, Bassetti S, Battegay M. 2011. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC Infect Dis 11: 319.
     
  43. Engelberger S, Giovannacci L, Van den Berg JC, Rosso R. 2011. Occlusion of Venous Femoropopliteal Bypass by a Starclose Device After Endovascular Cardiac Catheterization. Cardiovasc Intervent Radiol 34, no. 1 (Feb): 205-206.
     
  44. Espeli V, Zucca E, Ghielmini M, Giannini O, Salatino A, Martucci F, Richetti A. 2011. Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer. Oral Oncol 48, no. 8 (Mar): 266-271.
     
  45. Esposito F, Galfetti M, Lava SA, Balestra B, Bianchetti MG. 2011. Fetopathy probably associated to self-medication with a blocker of the renin-angiotensin system. Arch Gynecol Obstet 284, no. 5 (Nov): 1321.
     
  46. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Foá R, Pasqualucci L, Rabadan R, Dalla-Favera R, Gaidano G. 2011. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 208, no. 7 (Jul): 1389-1401.
     
  47. Fantini ML, Farini E, Ortelli P, Zucconi M, Manconi M, Cappa S, Ferini-Strambi L. 2011. Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder. Sleep 34, no. 5 (May): 619-625.
     
  48. Faré PB, Lava SA, Simonetti GD, Ramelli GP, Bianchetti MG. 2011. Blue breath-holding spells caused by an alcoholic vitamin D3 preparation in infancy. Acta Paediatr 100, no. 7 (Jul): e4.
     
  49. Fasolo A, Sessa C. 2011. Current and future directions in mammalian target of rapamycin inhibitors development. Expert Opinion on investigational drugs 20, no. 3 (Mar): 381-394. 
     
  50. Fehr J, Glass TR, Louvel S, Hamy F, Hirsch HH, von Wyl V, Böni J, Yerly S, Bürgisser P, Cavassini M, Fux CA, Hirschel B, Vernazza P, Martinetti G, Bernasconi E, Günthard HF, Battegay M, Bucher HC, Klimkait T, Swiss HIV Cohort Study. 2011. Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. J Transl Med 9: 14.
     
  51. Ferini-Strambi L, Pozzi P, Manconi M, Zucconi M, Oldani A. 2011. Bruxism and nocturnal groaning. Arch Ital Biol 149, no. 4 (Dec): e467-477.
     
  52. Ferrarini A, Auteri-Kaczmarek A, Pica A, Boesch N, Heinimann K, Schäfer SC, Vesnaver-Megalo S, Cina V, Beckmann JS, Monnerat C. 2011. Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53. Fam Cancer 10, no. 2 (Jun): 187-192.
     
  53. Fiore E, Rizzi M, Simonetti GD, Garzoni L, Bianchetti MG, Bettinelli A. 2011. Acute hemorrhagic edema of young children: a concise narrative review. Eur J Pediatr 170, no. 12 (Dec): 1507-1512.
     
  54. Fogliata A, Bergström S, Cafaro I, Clivio A, Cozzi L, Dipasquale G, Hållström P, Mancosu P, Navarria P, Nicolini G, Parietti E, Pesce GA, Richetti A, Scorsetti M, Vanetti E, Weber DC. 2011. Cranio-spinal irradiation with volumetric modulated arc therapy: a multi-institutional treatment experience. Radiother Oncol 99, no. 1 (Apr): 79-85.
     
  55. Fogliata A, Clivio A, Fenoglietto P, Hrbacek J, Kloeck S, Lattuada P, Mancosu P, Nicolini G, Parietti E, Urso G, Vanetti E, Cozzi L. 2011. Quality assurance of RapidArc in clinical practice using portal dosimetry. Br J Radiol 84, no. 1002 (Jun): 534-545.
     
  56. Fogliata A, Cozzi L, Clivio A, Ibatici A, Mancosu P, Navarria P, Nicolini G, Santoro A, Vanetti E, Scorsetti M. 2011. Preclinical assessment of volumetric modulated arc therapy for total marrow irradiation. Int J Radiat Oncol Biol Phys 80, no. 2 (Jun): 628-636.
     
  57. Fogliata A, Nicolini G, Clivio A, Vanetti E, Cozzi L. 2011. Accuracy of Acuros XB and AAA dose calculation for small fields with reference to RapidArcVR® stereotactic treatments. Med Phys 38, no. 11 (Nov): 6228-6237.
     
  58. Fogliata A, Nicolini G, Clivio A, Vanetti E, Cozzi L. 2011. Dosimetric evaluation of Acuros XB Advanced Dose Calculation algorithm in heterogeneous media. Radiat Oncol 19, no. 6 (Jul): 82.
     
  59. Fogliata A, Nicolini G, Clivio A, Vanetti E, Cozzi L. 2011. On the dosimetric impact of inhomogeneity management in the Acuros XB algorithm for breast treatment. Radiat Oncol 6: 103.
     
  60. Fogliata A, Nicolini G, Clivio A, Vanetti E, Mancosu P, Cozzi L. 2011. Dosimetric validation of the Acuros XB Advanced Dose Calculation algorithm: fundamental characterization in water. Phys Med Biol 56, no. 6 (Mar): 1879-1904.
     
  61. Furlan D, Carnevali IW, Bernasconi B, Sahnane N, Milani K, Cerutti R, Bertolini V, Chiaravalli AM, Bertoni F, Kwee I, Pastorino R, Carlo C. 2011. Hierarchical clustering analysis of pathologic and molecular data identifies prognostically and biologically distinct groups of colorectal carcinomas. Mod Pathol 24, no. 1 (Jan): 126-137. 
     
  62. Gabutti L, Nobile F, Forni V, Rigamonti F, Weibel N, Burnier M. 2011. Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: is it feasible? BMC Nephrol 18, no. 12 (Feb): 11.
     
  63. Gabutti L, Salvadé I, Lucchini B, Soldini D, Burnier M. 2011. Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids. BMC Nephrol 12: 14.
     
  64. Gerber B, Kyburz T, Reinhart WH, Bonetti PO, Stüssi G. 2011. Complement inhibition to treat myocardial infarction? BMJ Case Reports 26.
     
  65. Gerber B, Stüssi G. 2011. Reversibility of spur cell anemia. Blood 118, no. 16 (Oct): 4304.
     
  66. Gianella S, von Wyl V, Fischer M, Niederoest B, Battegay M, Bernasconi E, Cavassini M, Rauch A, Hirschel B, Vernazza P, Weber R, Joos B, Günthard HF; Swiss HIV Cohort Study.. 2011. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir Ther 16, no. 4: 535-545.
     
  67. Giovanella L, Castellani M, Suriano S, Ruberto T, Ceriani L, Tagliabue L, Lucignani G. 2011. Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer. Tumori 97, no. 5 (Sep-Oct): 629-633.
     
  68. Giovanella L, Ceriani L, Suriano S. 2011. Lymph node thyroglobulin measurement in diagnosis of neck metastases of differentiated thyroid carcinoma. J Thyroid Res, 2011.
     
  69. Giovanella L, Ceriani L. 2011. Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays. Clin Chem Lab Med 49, no. 6 (Jun): 1025-1027.
  70. Giovanella L, Suriano S, Castellani M, Ceriani L, Verburg FA. 2011. Thyroid remnant estimation by Tc-99m-sestamibi scanning predicts the effectiveness of rhTSH-stimulated I-131 ablation in patients with differentiated thyroid carcinoma. Clin Nucl Med 36, no. 9 (Sep): 781-785.
     
  71. Giovanella L, Suriano S, Ceriani L, Verburg FA. 2011. Undetectable thyroglobulin in patients with differentiated thyroid carcinoma and residual radioiodine uptake on a postablation whole-body scan. Clin Nucl Med 36, no. 2 (Feb): 109-112.
     
  72. Giovanella L, Suriano S, Keller F, Borretta G, Ceriani L. 2011. Evaluation of serum parathyroid hormone-related peptide in hyperthyroid patients. Eur J Clin Invest 41, no. 1 (Jan): 93-97.
     
  73. Giovanella L, Suriano S, Maffioli M, Ceriani L. 2011. 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology. Clin Endocrinol (Oxf) 74, no. 5 (May): 644-648.
     
  74. Giovanella L, Suriano S. 2011. Spurious hypercalcitoninemia and heterophilic antibodies in patients with thyroid nodules. Head Neck 33, no. 1 (Jan): 95-97.
     
  75. Giovanella L, Toffalori E, Ceriani L, Caputo M, Verburg FA. 2011. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma. Horm Metab Res 43, no. 10 (Sep): 728-730.
     
  76. Giovanella L, Verburg FA. 2011. Ruling out 131I ablation in low-risk differentiated thyroid carcinoma basing on thyroglobulin measurement. Thyroid 21, no. 7 (Jul): 809-810.
     
  77. Giovanella L. 2011. Thyroglobulin-guided (131)I ablation in low-risk differentiated thyroid carcinoma: is the yardstick accurate enough? Head Neck 33, no. 9 (Sep): 1379-1380.
     
  78. Gobbi C, Digesu GA, Khullar V, El Neil S, Caccia G, Zecca C. 2011. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Mult Scler 17, no. 12 (Dec): 1514-1519.
     
  79. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, Bertisch B, Bernasconi E, Weber R, Swiss HIV Cohort Study. 2011. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 53, no. 11 (Dec): 1130-1139.
     
  80. Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, PSP Genetics Study Group (Möller JC), Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Müller U, Schellenberg GD. 2011. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43, no. 7 (Jun): 699-705.
     
  81. Horat N, Rosso R, Remy C, Giovannacci L. 2011. Une colite ischémique particulière. Swiss Medical Forum 11, no. 4 (Jan): 65-67.
     
  82. Huber X, Kraus R, Kuhrmeier A, Rosso R. 2011. Anterolaterale Zwerchfellhernien (Morgagni-Hernie) bei Jung und Alt: zwei Beispiele. Swiss Medical Forum 11, no. 14 (Apr): 261-263.
     
  83. Isaak A, Ellrich J.. 2011. Neuronal nitric oxide synthase is involved in the induction of nerve growth factor-induced neck muscle nociception. Headache 51, no. 5 (May): 734-43.
     
  84. Jacquemont S, Reymond A, Zufferey F, Harewood L, Walters RG, Kutalik Z, Martinet D, Shen Y, Valsesia A, Beckmann ND et al (Ramelli GP). 2011. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 478, no. 7367  (Aug): 97-102.
     
  85. Kaufmann GR, Elzi L, Weber R, Furrer H, Giulieri S, Vernazza P, Bernasconi E, Hirschel B, Battegay M, Swiss HIV Cohort Study. 2011. Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS 25, no. 4 (Feb): 441-451.
     
  86. Kauther KM, Höft C, Rissling I, Oertel WH, Möller JC. 2011. The PLA2G6 gene in early-onset Parkinson's disease. Mov Disord 26, no. 13 (Nov): 2415-2417.
     
  87. Khatami R, Tartarotti S, Siccoli MM, Bassetti CL, Sándor PS. 2011.Long-term efficacy of sodium oxybate in 4 patients with chronic cluster headache. Neurology 77, no. 1 (Jul): 67-70.
  88. Klimusina J, Oberson M, Di Valentino M, Wyttenbach R, Alerci M, Menafoglio A, Gallino A. 2011. An unusual case of large vessel vasculitis associated with pyoderma gangrenosum. The natural history of the disease. Cardiovasc. Med. 14 (6): 185-188.
     
  89. Koeberle D, Ruhstaller T, Jost L, Pagani O, Zaman K, von Moos R, Oehlschlegel C, Crowe S, Pilop C, Thuerlimann B, Swiss Group for Clinical Cancer Research (SAKK). 2011. Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03). Endocr Relat Cancer 18, no. 2 (Mar): 257-264.
     
  90. Kolm I, Kamarashev J, Kerl K, Mainetti C, Giovanoli P, French LE, Braun RP. 2011. Diagnostic pitfall: pigmented lesion of the nipple--correlation between dermoscopy, reflectance confocal microscopy and histopathology. Dermatology 222, no. 1 (Feb):  1-4.
     
  91. Kouyos RD, von Wyl V, Yerly S, Böni J, Rieder P, Joos B, Taffé P, Shah C, Bürgisser P, Klimkait T, Weber R, Hirschel B, Cavassini M, Rauch A, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Bonhoeffer S, Günthard HF, Swiss HIV Cohort Study. 2011. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis 52, no. 4 (Feb): 532-539.
     
  92. Kwee I, Rancoita PM, Rinaldi A, Ferreri AJ, Bhagat G, Gascoyne RD, Canzonieri V, Gaidano G, Doglioni C, Zucca E, Ponzoni M, Bertoni F. 2011. Genomic profiles of MALT lymphomas: variability across anatomical sites. Haematologica 96, no. 7 (Jul): 1064-1066.
     
  93. Lava SA, Caccia G, Osmetti-Gianini S, Simonetti GD, Milani GP, Falesi M, Bianchetti MG. 2011. Acceptance of two liquid vitamin D3 formulations among mothers with newborn infants: a randomized, single-blind trial. Eur J Pediatr 170, no. 12 (Dec): 1569-1562.
     
  94. Lubomirov R, Colombo S, di Iulio J, Ledergerber B, Martinez R, Cavassini M, Hirschel B, Bernasconi E, Elzi L, Vernazza P, Furrer H, Günthard HF, Telenti A, Swiss HIV Cohort Study. 2011. Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study. J Infect Dis 203, no. 2 (Jan): 246-257.
     
  95. Lucchina S, Badia A, Nistor A, Fusetti C. 2011. Surgical treatment options for unstable mallet fractures. Plast Reconstr Surg 128, no. 2 (Aug): 599-600.
     
  96. Lucchina S, Becker HA, Fusetti C, Shin AY. 2011. Transient bone resorption following finger replantation: a report of 3 cases. Chin J Traumatol 14, no. 3 (Jun): 178-182.
     
  97. Lucchina S, Nistor A, Fusetti C. 2011. Post-traumatic combined flexion of the thumb, index and middle finger after intrinsic muscles reconstruction of the hand: a case report. Hand Surg 2 (16): 189-191.
     
  98. Lucchina S, Nistor A, Stricker H, Fusetti C. 2011. False aneurysm of the common digital artery. Is reconstruction with an arterial graft worth the efforts? A case report. Microsurgery 31, no. 3 (Mar): 246-250.
     
  99. Luigetti M, Cianfoni A, Modoni A, Conte A, Conti G, Sabatelli M. 2011. Teaching NeuroImages: cochleitis: a rare cause of acute deafness in a patient with HCV. Neurology 77, no. 18 (Nov): e109.
     
  100. Luigetti M, Cianfoni A, Scarano E, Laurenti L, Innocenti I, Testani E, Dittoni S, Della Marca G. 2011. Mycosis fungoides as a cause of severe obstructive sleep apnea. Intern Med 50, no. 16: 1753-1755.
     
  101. Luigetti M, Sabatelli M, Cianfoni A. 2011. Wernicke's encephalopathy following chronic diarrhoea. Acta Neurol Belg 111, no. 3 (Sep): 257. 
     
  102. Magenta L, Dell-Kuster S, Richter WO, Young J, Hasse B, Flepp M, Hirschel B, Vernazza P, Evison J, Cavassini M, Decosterd LA, Bucher HC, Bernasconi E, Swiss HIV Cohort Study. 2011. Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy. AIDS Res Hum Retroviruses 27, no. 5 (May): 525-533.
     
  103. Manconi M, Ferri R, Zucconi M, Clemens S, Giarolli L, Bottasini V, Ferini-Strambi L. 2011. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome. Neurology 77, no. 2 (Jul): 110-117.
     
  104. Manconi M, Ferri R, Zucconi M, Clemens S, Rundo F, Oldani A, Ferini-Strambi L. 2011. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep. Sleep Med 2, no. 1 (Jan): 47.55.
     
  105. Manconi M, Ferri R, Zucconi M, Oldani A, Giarolli L, Bottasini V, Ferini-Strambi L. 2011. Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome. Mov Disord 26, no. 5 (Apr): 892-895.
     
  106. Mancosu P, Danna M, Bettinardi V, Aquilina MA, Lobefalo F, Cozzi L, Fogliata A, Scorsetti M. 2011. Semiautomatic method to identify the best phase for gated RT in lung region by 4D-PET/CT acquisitions. Med Phys 38, no. 1 (Jan): 354-362.
     
  107. Marazza G, Beltraminelli H, Mainetti C. 2011. Erythema scarlatiniforme desquamativum recidivans (Féréol-Besnier)--report of three cases localized to the thumb. Dermatology 223, no. 3 (Dec): 216-218.
     
  108. Martin C, von Elm E, El-Koussy M, Boltshauser E, Steinlin M, Swiss Neuropediatric Stroke Registry study group (Ramelli GP). 2011. Delayed diagnosis of acute ischemic stroke in children - a registry-based study in Switzerland. Swiss Med Wkly 141: w13281. 
     
  109. Marzolini C, Back D, Weber R, Furrer H, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Khoo S, Battegay M, Elzi L, Swiss HIV Cohort Study. 2011. Ageing with HIV: medication use and risk for potential drug-drug interactions. J Antimicrob Chemother 66, no. 9 (Sep): 2017-2111.
     
  110. Mascetti L, Bettinelli A, Simonetti GD, Tagliabue A, Syrén ML, Nordio F, Bianchetti MG. 2011. Pregnancy in inherited hypokalemic salt-losing renal tubular disorder. Obstet Gynecol 117, 2 Pt 2 (Feb): 512-516.
     
  111. Mazzoni MB, Kottanatu L, Simonetti GD, Ragazzi M, Bianchetti MG, Fossali EF, Milani GP. 2011. Renal vein obstruction and orthostatic proteinuria: a review. Nephrol Dial Transplant 26, no. 2 (Feb): 562-565.
     
  112. Mazzucchelli S, Verderio P, Sommaruga S, Colombo M, Salvadè A, Corsi F, Galeffi P, Tortora P, Prosperi D. 2011. Multiple presentation of Scfv800E6 on silica nanospheres enhances targeting efficiency toward HER-2 receptor in breast cancer cells. Bioconjug Chem 22, no. 11 (Nov): 2296-2303.
     
  113. Merlani P, Verdon M, Businger A, Domenighetti G, Pargger H, Ricou B. 2011. Burnout in ICU caregivers:a multicenter study of factors associated to centers. Am J Respir Crit Care Med 184, no. 10 (Nov): 1140-1146.
     
  114. Molinari F, Felicioni L, Buscarino M, De Dosso S, Buttitta F, Malatesta S, Movilia A, Luoni M, Boldorini R, Alabiso O, Girlando S, Soini B, Spitale A, Di Nicolantonio F, Saletti P, Crippa S, Mazzucchelli L, Marchetti A, Bardelli A, Frattini M. 2011. Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. Clin Cancer Res 17, no. 14 (Jul): 4901-4914.
     
  115. Mueller RJ, Stüssi G, Puga Yung G, Nikolic M, Soldini D, Halter J, Meyer-Monard S, Gratwohl A, Passweg JR, Odermatt B, Schanz U, Biedermann BC, Seebach JD. 2011. Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation. Haematologica 96, no. 1 (Jan): 119-127.
     
  116. Mylius V, Brebbermann J, Dohmann H, Engau I, Oertel WH, Möller JC. 2011. Pain sensitivity and clinical progression in Parkinson's disease. Mov Disord 26, no. 12 (Oct): 2220-2225.
     
  117. Nava S, Grassi M, Fanfulla F, Domenighetti G, Carlucci A, Perren A, Dell'Orso D, Vitacca M, Ceriana P, Karakurt Z, Clini E. 2011. Non-invasive ventilation in elderly patients with acute hypercapnic respiratory failure: a randomised controlled trial. Age Ageing 44, no. 4 (Jul): 444-450.
     
  118. Nava S, Schreiber A, Domenighetti G. 2011. Non-invasive ventilation for patients with acute lung injury or acute respiratory distress syndrome. Respir Care 10, no. 56 (Oct): 1583-1588.
     
  119. Nguyen A, Calmy A, Delhumeau C, Mercier IK, Cavassini M, Fayet-Mello A, Elzi L, Genné D, Rauch A, Bernasconi E, Hirschel B, Swiss HIV Cohort Study. 2011. A randomized crossover study to compare efavirenz and etravirine treatment. AIDS 25, no. 1 (Jan): 57-63.
     
  120. Nicolini G, Clivio A, Cozzi L, Fogliata A, Vanetti E. 2011. On the impact of dose rate variation upon RapidArc® implementation of volumetric modulated are therapy. Med Phys 38, no. 1 (Jan): 264-271.
     
  121. Nicolini G, Fogliata A, Clivio A, Vanetti E, Cozzi L. 2011. Planning strategies in volumetric modulated are therapy for breast. Med Phys 38, no. 7 (Jul): 4025-4031.
     
  122. Nicolosi Guidicelli S, Lopez-Guillermo A, Falcone U, Conconi A, Christinat A, Rodriguez-Abreu D, Grisanti S, Lobetti-Bodoni C, Piffaretti JC, Johnson PW, Mombelli G, Cerny A, Montserrat E, Cavalli F, Zucca E. 2011. Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group. Hematol Oncol, (Nov): in press.
     
  123. Nielsen TB, Wieslander E, Fogliata A, Nielsen M, Hansen O, Brink C. 2011. Influence of dose calculation algorithms on the predicted dose distribution and NTCP values for NSCLC patients. Med Phys 38, no. 5 (May): 2412-2418.
     
  124. Nigro G, Giovannacci L, Engelberger S,  Van den Berg JC, Rosso R. 2011. The challenge of posttraumatic thrombus embolization from abdominal aortic aneurysm causing acute limb ischemia. J Vasc Surg 54, no. 3 (Sep): 840-843.
     
  125. Oberholzer M, Poryazova R, Bassetti CL. 2011. Sleepwalking in Parkinson's disease: a questionnaire-based survey. J Neurol 258, no. 7 (Jul): 1261-1267.
     
  126. Occhipinti E, Verderio P, Natalello A, Galbiati E, Colombo M, Mazzucchelli S, Salvadè A, Tortora P, Doglia SM, Prosperi D. 2011. Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles. Nanoscale 3, no. 2 (Feb): 387-390.
     
  127. Orth M, European Huntington's Disease Network (Möller JC), Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB. 2011. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. J Neurol Neurosurg Psychiatry 82, no. 12 (Dec): 1409-1411.
     
  128. Orth M; Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB, Investigators of the European Huntington's Disease Network (Möller JC). 2011. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. J Neurol Neurosur Ps 82 (12): 1409-1412.
     
  129. Ortiz M, Poloni ES, Furrer H, Kovari H, Martinez R, Arnedo M, Elzi L, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Ledergerber B, Günthard HF, Telenti A, Tarr PE, Swiss HIV Cohort Study. 2011. No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis 203, no. 5 (Mar): 620-624.
     
  130. Ortmann O, Pagani O, Jones A, Maass N, Noss D, Rugo H, van de Velde C, Aapro M, Coleman R. 2011. Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel. Cancer Treat Rev 37, no. 2 (Apr): 97-104.
     
  131. Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Gelber R, Goldhirsch A, Breast International Group, North American Breast Cancer Group Endocrine Working Group. 2011. Pregnancy after breast cancer: if you wish, ma'am. Breast Cancer Res Treat 129, no. 2 (Sep): 309-317.
     
  132. Perren A, Markmann M, Merlani G, Marone C, Merlani P. 2011. Fluid balance in critically ill patients. Should we really rely on it? Minerva Anestesiol 77, no. 8 (Aug): 802-811.
     
  133. Phillips KA, Aldridge J, Ribi K, Sun Z, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J. 2011. Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast Cancer Res Treat 126, no. 1 (Feb): 221-226.
     
  134. Pons M. 2011. Pulmonary embolism - a 1924 contribution and comment from the current point of view. Praxis (Bern 1994) 100, no. 18 (Sep): 1082-1084.
     
  135. Poretti G, Kwee I, Bernasconi B, Rancoita PM, Rinaldi A, Capella C, Zucca E, Neri A, Tibiletti MG, Bertoni F. 2011. Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines. Leuk Res 35, no. 6 (Jun): 808-813.
     
  136. Poryazova R, Tartarotti S, Khatami R, Baumann CR, Valko P, Kallweit U, Werth E, Bassetti CL. 2011. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience. Eur Neurol 65 (3): 175-182.
     
  137. Poryazova R, Werth E, Parrino L, Terzano MG, Bassetti CL. 2011. Cyclic alternating pattern in narcolepsy patients and healthy controls after partial and total sleep deprivation. Clin Neurophysiol 122, no. 9 (Sep): 1788-1793.
     
  138. Ramelli GP, Cortesi C, Boscherini D, Faggin R, Bianchetti MG. 2011. Age-dependent presentation of tectal plate tumors: preliminary observations. J Child Neurol 26, no. 3 (Mar): 377-380.
     
  139. Rasi S, Bruscaggin A, Rinaldi A, Cresta S, Fangazio M, De Paoli L, Monti S, Gargiulo E, Kwee I, Foà R, Bertoni F, Gaidano G, Rossi D. 2011. Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia. Leuk Res 35, no. 10 (Oct): 1419-1422.
     
  140. Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U, Rancoita PM, De Campos CP, Forconi F, Gascoyne RD, Facchetti F, Ponzoni M, Govi S, Ferreri AJ, Mollejo M, Piris MA, Baldini L, Soulier J, Thieblemont C, Canzonieri V, Gattei V, Marasca R, Franceschetti S, Gaidano G, Tucci A, Uccella S, Tibiletti MG, Dirnhofer S, Tripodo C, Doglioni C, Dalla Favera R, Cavalli F, Zucca E, Kwee I, Bertoni F. 2011. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 117, no. 5 (Feb): 1595-1604.
     
  141. Rinaldi A, Ponzoni M, Uccella S, Rossi D, Gaidano G, Facchetti F, Pruneri G, Tibiletti MG, Capella C, Zucca E, Doglioni C, Catapano C, Bertoni F. 2011. In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas. Hematol Oncol 29, no. 3 (Sep): 164-166.
     
  142. Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M, Fangazio M, Vaisitti T, Monti S, Chiaretti S, Guarini A, Del Giudice I, Cerri M, Cresta S, Deambrogi C, Gargiulo E, Gattei V, Forconi F, Bertoni F, Deaglio S, Rabadan R, Pasqualucci L, Foà R, Dalla-Favera R, Gaidano G. 2011. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 118, no. 26 (Dec): 6904-6908.
     
  143. Rossi D, Deaglio S, Dominguez-Sola D, Rasi S, Vaisitti T, Agostinelli C, Spina V, Bruscaggin A, Monti S, Cerri M, Cresta S, Fangazio M, Arcaini L, Lucioni M, Marasca R, Thieblemont C, Capello D, Facchetti F, Kwee I, Pileri SA, Foà R, Bertoni F, Dalla-Favera R, Pasqualucci L, Gaidano G. 2011. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma. Blood 118, no. 18 (Nov): 4930-4934.
     
  144. Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K, Arcaini L, Lucioni M, Rocque GB, Xu-Monette ZY, Visco C, Chang J, Chigrinova E, Forconi F, Marasca R, Besson C, Papadaki T, Paulli M, Larocca LM, Pileri SA, Gattei V, Bertoni F, Foà R, Young KH, Gaidano G. 2011. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 117, no. 12 (Mar): 3391-3401.
     
  145. Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger SE, Martinez R, Sandler NG, Roque A, Liebner J, Battegay M, Bernasconi E, Descombes P, Erkizia I, Fellay J, Hirschel B, Miró JM, Palou E, Hoffmann M, Massanella M, Blanco J, Woods M, Günthard HF, de Bakker P, Douek DC, Silvestri G, Martinez-Picado J, Telenti A. 2011. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 121, no. 6 (Jun): 2391-2400.
     
  146. Saletti P, Sessa C, De Dosso S, Cerny T, Renggli V, Koeberle D. 2011. Phase I dose-finding study of vandetanib in combination with gemcitabine in locally advanced unresectable or metastatic pancreatic adenocarcinoma. Oncology 81, no. 1: 50-54.
     
  147. Salvati A, Ferrari C, Chiumarulo L, Medicamento N, Dicuonzo F, De Blasi R. 2011. Endovascular treatment of brain arteriovenous malformations ruptured during pregnancy - a report of two cases. J Neurol Sci 308, no. 1-2 (Sep): 158-161.
     
  148. Samaras P, Blickenstorfer M, Haile SR, Siciliano RD, Petrausch U, Mischo A, Zweifel M, Honegger H, Schanz U, Stüssi G, Taverna C, Bauer S, Knuth A, Stenner-Liewen F, Renner C. 2011. Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss Med Wkly, 141: w13203.
     
  149. Samaras P, Blickenstorfer M, Siciliano RD, Haile SR, Buset EM, Petrausch U, Mischo A, Honegger H, Schanz U, Stüssi G, Stahel RA, Knuth A, Stenner-Liewen F, Renner C. 2011. Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim. Ann Hematol 90, no. 1 (Jan): 89-94.
     
  150. Sax H, Uçkay I, Balmelli C, Bernasconi E, Boubaker K, Mühlemann K, Ruef C, Troillet N, Widmer A, Zanetti G, Pittet D. 2011. Overall burden of healthcare-associated infections among surgical patients. Results of a national study. Ann Surg 253, no. 2 (Feb): 365-370.
     
  151. Scherrer AU, Ledergerber B, von Wyl V, Böni J, Yerly S, Klimkait T, Bürgisser P, Rauch A, Hirschel B, Cavassini M, Elzi L, Vernazza PL, Bernasconi E, Held L, Günthard HF, Swiss HIV Cohort Study. 2011. Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clin Infect Dis 53, no. 11 (Dec): 1143-1152.
     
  152. Scherrer AU, von Wyl V, Böni J, Yerly S, Klimkait T, Bürgisser P, Garzoni C, Hirschel B, Cavassini M, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF, Swiss HIV Cohort Study. 2011.Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 57, no. 1 (May): 24-31.
     
  153. Scorsetti M, Alongi F, Castiglioni S, Clivio A, Fogliata A, Lobefalo F, Mancosu P, Navarria P, Palumbo V, Pellegrini C, Pentimalli S, Reggiori G, Ascolese AM, Roggio A, Arcangeli S, Tozzi A, Vanetti E, Cozzi L. 2011. Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments. Radiat Oncol, 6: 113.
     
  154. Scorsetti M, Bignardi M, Alongi F, Fogliata A, Mancosu P, Navarria P, Castiglioni S, Pentimalli S, Tozzi A, Cozzi L. 2011. Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: feasibility and clinical preliminary results. Acta Oncol 50, no. 4 (May): 528-538.
     
  155. Scorsetti M, Mancosu P, Navarria P, Tozzi A, Castiglioni S, Clerici E, Reggiori G, Lobefalo F, Fogliata A, Cozzi L. 2011. Stereotactic body radiation therapy (SBRT) for adrenal metastases: a feasibility study of advanced techniques with modulated photons and protons. Strahlenther Onkol 187, no. 4 (Apr): 238-244.
     
  156. Sessa C, D’Incalci M. 2011. Trabectedin in ovarian cancer: could we expect more? Ann Oncol 22, no. 1 (Jan): 7-8.
     
  157. Sessa C. 2011. Update on PARP1 inhibitors in ovarian cancer. Ann Oncol Suppl 22, Suppl. 8 (Dec): viii72-viii76.
     
  158. Siclari F, Nobili L, Lo Russo G, Moscato A, Buck A, Bassetti CL, Khatami R. 2011. Stimulus-induced, sleep-bound, focal seizures: a case report. Sleep 34, no. 12 (Dec): 1727-1730.
     
  159. Siclari F, Wienecke M, Poryazova R, Bassetti CL, Baumann CR. 2011. Laughing as a manifestation of rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord 17, no. 5 (Jun): 382-385.
     
  160. Sommaruga S, Lombardi A, Salvadè A, Mazzucchelli S, Corsi F, Galeffi P, Tortora P, Prosperi D. 2011. Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells. Appl Microbiol Biotechnol 91(3): 613-621.
     
  161. Suriano S, Ceriani L, Gertsch P, Crippa S, Giovanella L. 2011. Accessory spleen mimicking a pancreatic neuroendocrine tumor. Tumori 97, no. 6 (Nov-Dec): 39e-41e.
     
  162. Szucs-Farkas Z, Schibler F, Cullmann J, Torrente JC, Patak MA, Raible S, Hoppe H, Wyttenbach R, Vock P, Schindera ST. 2011. Diagnostic accuracy of pulmonary CT angiography at low tube voltage: intraindividual comparison of a normal-dose protocol at 120 kVp and a low-dose protocol at 80 kVp using reduced amount of contrast medium in a simulation study. American Journal of Roentgenology 197, no. 5 (Nov): w852-w859.
     
  163. Tarr P, Wirz S, Fleisch F, Strohmeier P, Bernasconi E, Senn L. 2011. Refroidissement, mal de gorge, toux, bronchite, grippe – les infections respiratoires aiguës dans la pratique. Swiss Medical Forum 11, no. 48: 873-878.
     
  164. Tarr PE, Schweizer M, Lampert M, Chapuis-Taillard C, Bernasconi E, Senn L. 2011. Antibiotiques les plus importants en ambulatoire. Swiss Medical Forum 11(16-17): 290-295.
     
  165. Testoni M, Kwee I, Greiner TC, Montes-Moreno S, Vose J, Chan WC, Chiappella A, Baldini L, Ferreri AJ, Gaidano G, Mian M, Zucca E, Bertoni F. 2011. Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP. Br J Haematol 155, no. 2 (Oct): 274-277.
     
  166. Thierfelder C, Weber R, Elzi L, Furrer H, Cavassini M, Calmy A, Bernasconi E, Gutmann C, Ledergerber B, Swiss HIV Cohort Study. 2011. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Med 13, no. 2 (Feb): 118-126.
     
  167. Tiraboschi P, Chitò E, Sacco L, Sala M, Stefanini S, Defanti CA. 2011.Evaluating voting competence in persons with Alzheimer disease. Int J Alzheimers Dis, 2011: 983895, 6 pages.
     
  168. Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P, Hill D, Anderson T, Myllyla V, Kassubek J, Steiger M, Zucconi M, Tolosa E, Poewe W, Surmann E, Whitesides J, Boroojerdi B, Chaudhuri KR, Recover Study Group (Möller JC). 2011. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26, no. 1 (Jan): 90-99.
     
  169. Uncini A, Notturno F, Pace M, Caporale CM. 2011. Polymorphism of CD1 and SH2D2A genes in inflammatory neuropathies. J Peripher Nerv Syst Suppl 16, no. 6 (Jun): 48-51.
     
  170. Unger MM, Möller JC, Mankel K, Eggert KM, Bohne K, Bodden M, Stiasny-Kolster K, Kann PH, Mayer G, Tebbe JJ, Oertel WH. 2011.Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease? J Neurol 258, no. 6 (Jun): 982-990.
     
  171. Unger MM, Möller JC, Mankel K, Schmittinger K, Eggert KM, Stamelou M, Stiasny-Kolster K, Bohne K, Bodden M, Mayer G, Oertel WH, Tebbe JJ. 2011. Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath test. Mov Disord 14, no. 26 (Dec): 2559-2563.
     
  172. Van den Berg JC. 2011. Imaging of the thoracic aorta. Presse Med 40, no. Part 2 (Sep): e391-e412.
     
  173. Vanetti E, Nicolini G, Nord J, Peltola J, Clivio A, Fogliata A, Cozzi L. 2011. On the role of the optimization algorithm of RapidArcVR® volumetric modulated arc therapy on plan quality and efficiency. Med Phys 11, no. 38 (Nov): 5844-5856.
     
  174. Vidal L, Gafter-Gvili A, Salles G, Dreyling MH, Ghielmini M, Hsu Schmitz SF, Pettengell R, Witzens-Harig M, Shpilberg O. 2011. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials. J Natl Cancer Inst 23, no. 103 (Dec): 1799-1806.
     
  175. Von Wyl V, Kouyos RD, Yerly S, Böni J, Shah C, Bürgisser P, Klimkait T, Weber R, Hirschel B, Cavassini M, Staehelin C, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Bonhoeffer S, Günthard HF, Swiss HIV Cohort Study. 2011. The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 7, no. 204 (Oct): 1095-1103.
     
  176. Vu MH, Hurni C, Mathis J, Roth C, Bassetti CL. 2011. Selective REM sleep deprivation in narcolepsy. J Sleep Res (1 pt 1), no. 20 (Mar): 50-56.
     
  177. Wandeler G, Keiser O, Hirschel B, Günthard HF, Bernasconi E, Battegay M, Clerc O, Vernazza PL, Furrer H, Swiss HIV Cohort Study. 2011.A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. PLoS One 12, no. 6: e27903.
     
  178. Wannesson L, Chigrinova E. 2011. Concordant and discordant bone marrow involvement in diffuse large B-cell lymphoma: are they understudied phenomena? Clin Oncol 3, no. 30 (Jan): 336.
     
  179. Wannesson L, Luthi F, Zucca E, Rosselet-Christ A, Baglioni M, Marelli L, Ghielmini M, Ketterer N. 2011. Pegfilgrastim to accelerate neutrophil engraftment following peripheral blood stem cell transplant and reduce the duration of neutropenia, hospitalization, and use of intravenous antibiotics: a phase II study in multiple myeloma and lymphoma and comparison with filgrastim-treated matched controls. Leuk Lymphoma 3, no. 52 (Mar): 436-443.
     
  180. Wissing FR, Balestra B. 2011. Das «Crowned-dens»-Syndrom . Swiss Medical Forum 6, no. 11 (Feb): 112.
     
  181. Wyl V, Gianella S, Fischer M, Niederoest B, Kuster H, Battegay M, Bernasconi E, Cavassini M, Rauch A, Hirschel B, Vernazza P, Weber R, Joos B, Günthard HF, Swiss HIV Cohort Study. 2011. Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS One 11, no. 6: e27463.
     
  182. Young J, Scherrer AU, Günthard HF, Opravil M, Yerly S, Böni J, Rickenbach M, Fux CA, Cavassini M, Bernasconi E, Vernazza P, Hirschel B, Battegay M, Bucher HC, Swiss HIV Cohort Study. 2011. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 5, no. 12 (May): 299-307.
     
  183. Zecca C, Gobbi C. 2011. Chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis (MS): a critical review. CNS Neurol Disord Drug Targets 6, no. 10 (Sep): 757-761.
     
  184. Zecca C, Petrini L, Limoni C, Städler C, Gobbi C. 2011. Tolerability and acceptance of prolonged, low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis. Eur Neurol 1, no. 65: 40-45.
     
  185. Zecca C, Petrini L, Limoni C, Staedler C, Gobbi C. 2011. Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis. Eur Neurol 1, no. 65: 40-45.
     
  186. Zeidler K, Arn K, Senn O, Schanz U, Stüssi G. 2011. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion 11, no. 51 (Nov): 2269-2276.
     
  187. Zunzunegui C, Gao B, Cam E, Hodor A, Bassetti CL. 2011. Sleep disturbance impairs stroke recovery in the rat. Sleep 9, no. 34 (Sep): 1261-1269.

 

Ultimo aggiornamento: 26 giugno 2015
X

PARTECIPA
AL SONDAGGIO

1 minuto - 6 domande!

RISPONDI